Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis

Abstract

IMPORTANCE Sepsis is a heterogeneous syndrome. Identification of distinct clinical phenotypes may allow more precise therapy and improve care. OBJECTIVE To derive sepsis phenotypes from clinical data, determine their reproducibility and correlation with host-response biomarkers and clinical outcomes, and assess the potential causal relationship with results from randomized clinical trials (RCTs). DESIGN, SETTINGS, AND PARTICIPANTS Retrospective analysis of data sets using statistical, machine learning, and simulation tools. Phenotypes were derived among 20 189 total patients (16 552 unique patients) who met Sepsis-3 criteria within 6 hours of hospital presentation at 12 Pennsylvania hospitals (2010-2012) using consensus k means clustering applied to 29 variables. Reproducibility and correlation with biological parameters and clinical outcomes were assessed in a second database (2013-2014; n = 43 086 total patients and n = 31 160 unique patients), in a prospective cohort study of sepsis due to pneumonia (n = 583), and in 3 sepsis RCTs (n = 4737). EXPOSURES All clinical and laboratory variables in the electronic health record. MAIN OUTCOMES AND MEASURES Derived phenotype (α, β, γ, and δ) frequency, host-response biomarkers, 28-day and 365-day mortality, and RCT simulation outputs. RESULTS The derivation cohort included 20 189 patients with sepsis (mean age, 64 [SD, 17] years; 10 022 [50%] male; mean maximum 24-hour Sequential Organ Failure Assessment [SOFA] score, 3.9 [SD, 2.4]). The validation cohort included 43 086 patients (mean age, 67 [SD, 17] years; 21 993 [51%] male; mean maximum 24-hour SOFA score, 3.6 [SD, 2.0]). Of the 4 derived phenotypes, the α phenotype was the most common (n = 6625; 33%) and included patients with the lowest administration of a vasopressor; in the β phenotype (n = 5512; 27%), patients were older and had more chronic illness and renal dysfunction; in the γ phenotype (n = 5385; 27%), patients had more inflammation and pulmonary dysfunction; and in the δ phenotype (n = 2667; 13%), patients had more liver dysfunction and septic shock. Phenotype distributions were similar in the validation cohort. There were consistent differences in biomarker patterns by phenotype. In the derivation cohort, cumulative 28-day mortality was 287 deaths of 5691 unique patients (5%) for the α phenotype; 561 of 4420 (13%) for the β phenotype; 1031 of 4318 (24%) for the γ phenotype; and 897 of 2223 (40%) for the δ phenotype. Across all cohorts and trials, 28-day and 365-day mortality were highest among the δ phenotype vs the other 3 phenotypes (P < .001). In simulation models, the proportion of RCTs reporting benefit, harm, or no effect changed considerably (eg, varying the phenotype frequencies within an RCT of early goal-directed therapy changed the results from >33% chance of benefit to >60% chance of harm). CONCLUSIONS AND RELEVANCE In this retrospective analysis of data sets from patients with sepsis, 4 clinical phenotypes were identified that correlated with host-response patterns and clinical outcomes, an...

Sepsis in Older Adults in Long‐Term Care Facilities: Challenges in Diagnosis and Management

“…Artificial intelligence was used to define differing phenotypes of sepsis, demonstrating the heterogeneity of the condition. 29 Use of artificial intelligence embedded in electronic medical records looking for changes in vital parameters by collecting and analyzing longitudinal data on routine assessments may play an important role in the early identification of risk for sepsis as well as a number of other conditions in the LTCF population.…”

Phenotypic heterogeneity by site of infection in surgical sepsis: a prospective longitudinal study

“…Once triggered, this systemic process was believed to progress independent of the inciting infection and thus patients with different types of infection have been grouped together in clinical trials [7]. Unfortunately, innumerable trials of promising immune-modulating interventions have failed to reduce early mortality and the recent consensus is that heterogeneity played a major role in these dismal failures [8][9][10]. It has been shown that site of infection is an independent predictor of early mortality [11][12][13][14][15].…”

ARDS Subphenotypes: Understanding a Heterogeneous Syndrome

“…Gårdlund et al used latent class analysis to identify six distinct subphenotypes of septic shock using clinical data from a previous large clinical trial cohort [47]. Seymour et al used a different approach (machine learning applied to electronic health record data) and identified four subphenotypes with different genetic and inflammatory markers and markedly different mortality rates [48].…”